| New synthetic inhibitors of fatty acid synthase with anticancer activity C Turrado, T Puig, J García-Cárceles, M Artola, B Benhamú, ... Journal of medicinal chemistry 55 (11), 5013-5023, 2012 | 79 | 2012 |
| Recent Methodologies That Exploit Oxidative Addition of C–N Bonds to Transition Metals J Garcı́a-Cárceles, KA Bahou, JF Bower ACS Catalysis 10 (21), 12738-12759, 2020 | 60 | 2020 |
| A new serotonin 5-HT6 receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding JA González-Vera, RA Medina, M Martín-Fontecha, A Gonzalez, ... Scientific reports 7 (1), 41293, 2017 | 47 | 2017 |
| Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells MJ Bueno, V Jimenez-Renard, S Samino, J Capellades, A Junza, ... Nature communications 10 (1), 5011, 2019 | 45 | 2019 |
| A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity J Garcia-Carceles, JM Decara, H Vazquez-Villa, R Rodriguez, ... Journal of Medicinal Chemistry 60 (23), 9575-9584, 2017 | 40 | 2017 |
| Kinase inhibitors as underexplored antiviral agents J García-Cárceles, E Caballero, C Gil, A Martínez Journal of medicinal chemistry 65 (2), 935-954, 2021 | 33 | 2021 |
| Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods T Ginex, U Garaigorta, D Ramírez, V Castro, V Nozal, I Maestro, ... Pharmaceuticals 14 (4), 332, 2021 | 26 | 2021 |
| Complex Polyheterocycles and the Stereochemical Reassignment of Pileamartine A via Aza-Heck Triggered Aryl C–H Functionalization Cascades BT Jones, J García-Cárceles, L Caiger, IR Hazelden, RJ Lewis, T Langer, ... Journal of the American Chemical Society 143 (38), 15593-15598, 2021 | 22 | 2021 |
| Discovery of V-0219: a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor toward oral treatment for “diabesity” JM Decara, H Vázquez-Villa, J Brea, M Alonso, RK Srivastava, L Orio, ... Journal of medicinal chemistry 65 (7), 5449-5461, 2022 | 7 | 2022 |
| 2-(fluoromethoxy)-4′-(s-methanesulfonimidoyl)-1, 1′-biphenyl (UCM-1306), an orally bioavailable positive allosteric modulator of the human dopamine D1 receptor for Parkinson … J García-Cárceles, H Vázquez-Villa, J Brea, ... Journal of Medicinal Chemistry 65 (18), 12256-12272, 2022 | 5 | 2022 |
| Novel Strategies Targeting G‐Protein‐Coupled Receptors: An Overview J García‐Cárceles eLS, 1-9, 2018 | | 2018 |
| A new serotonin 5-HT6 receptor antagonist with procognitive activity JA González-Vera, RA Medina, M Martín-Fontecha, A Gonzalez, ... | | 2017 |
| Allosteric modulators of serotonin and dopamine receptors: new drugs on GPCRs JG Carceles Universidad Complutense de Madrid, 2017 | | 2017 |
